PeopleBio, Inc. (KOSDAQ:304840)
South Korea · Delayed Price · Currency is KRW 759.00
-41.00 (-5.13%)
At close: Feb 27, 2026
PeopleBio Market Cap
PeopleBio has a market cap or net worth of 16.07 billion as of February 27, 2026. Its market cap has decreased by -71.99% in one year.
Market Cap
16.07B
Enterprise Value
24.40B
Revenue
3.36B
Ranking
n/a
PE Ratio
n/a
Stock Price
759.00
Market Cap Chart
Since October 19, 2020, PeopleBio's market cap has decreased from 127.63B to 16.07B, a decrease of -87.41%. That is a compound annual growth rate of -32.06%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 27, 2026 | 16.07B | -29.00% |
| Dec 30, 2025 | 22.63B | -64.95% |
| Dec 30, 2024 | 64.57B | -0.15% |
| Dec 28, 2023 | 64.67B | -65.14% |
| Dec 29, 2022 | 185.49B | 1.48% |
| Dec 30, 2021 | 182.78B | -36.77% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Oct 19, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| 3billion | 458.95B |
| Dx & Vx | 453.76B |
| Cytogen | 126.42B |
| GENINUS | 117.06B |
| HLB Panagene | 90.85B |
| Green Cross Medical Science | 82.84B |
| Protia | 69.28B |
| Seoulin Bioscience | 58.08B |